论文信息 - A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations - 字舞流文

A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations

M. Konopleva | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | N. Pemmaraju | N. Jain | N. Short | S. Loghavi | A. Maiti | G. Montalban-Bravo | K. Chien | M. Kwari | S. Desikan | W. Macaron | R. Delumpa